XTL Biopharmaceuticals (XTLB) Stock Highlights

1.88 | +2.73%

2024-11-23 06:46:33

XTL Biopharmaceuticals Ltd is engaged in the development of therapeutics for the treatment of unmet medical needs. Its products include hCDR1 and Recombinant Human Erythropoietin (rHuEPO). hCDR1 is a Phase II-ready asset compound, working through a mechanism of action, for the treatment of Systemic Lupus Erythematosus (SLE). hCDR1 is a synthetic peptide that includes approximately 20 amino-acid residues. rHuEPO, a known agent for anemia, is being developed to prolong the survival of patients with advanced multiple myeloma (MM). rHuEPO is used in clinical practice for the treatment of various anemias, including anemia of kidney disease and cancer-related anemia.

Statistics

Range Today

1.69 1.88

Volume Today 2.8K

Range 1 Year

0.76 4.99

Volume 1 Year 51.27M

Range 3 Year

0.75 4.99

Volume 3 Year 54.93M

Range 10 Year

0.63 14.35

Volume 10 Year 106.72M

Highlights

Market Capitalization 10.03M (micro)

Floating Shares 487.72M

Current Price 1.88

Price To Earnings -61.33

Price To Book 368

Earnings Per Share -0.03

Payout Ratio 0%

Performance

Latest +2.73%

1 Month -3.09%

3 Months -33.8%

6 Months -29.06%

1 Year +82.52%

3 Years -43.88%

5 Years +42.42%

10 Years -83.51%

Benchmarks

Market Capitalization

361 / 368

Gross Profits

0 / 278

Total Revenue

0 / 300

Total Rank

73 / 368

Free Cashflow

0 / 352

Performance 5 years

101 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.